About Us

At a Glance:

The ‘Omics for Assessing Signatures for Integrated Safety (OASIS) Consortium was officially convened in July 2023 between the non-profit Health and Environmental Sciences Institute (HESI) and the Broad Institute of Harvard and MIT. The Consortium is supported by an award from the Massachusetts Life Sciences Center (MLSC), in synergy with partnered resources and expertise from industry partners and in-kind contributions from academic, government, NGO, and biotech partners. This exciting effort engages >60 global experts in toxicology, cell biology, bioinformatics, risk assessment, and assay development from more from 15 academic institutes, 7 government agencies, 16 industry organizations, and 2 non-government organizations. 

 

Leadership

Co-Chairs

annecarpenter

Dr. Anne Carpenter

Broad Institute

Public Sector Lead

David Rouquie

Dr. David Rouquie

Bayer Crop Science

AgChem Sector Co-Lead

Postdocs

Dr. Srijit Seal

Dr. Srijit Seal

Broad Institute

Dr. Jessica Ewald

Dr. Jessica Ewald

Broad Institute

Steering Committee

Dr. Shantanu Singh

Dr.  Shantanu Singh

Broad Institute

MLSC Award Lead PI CP Data Extraction Workstream Lead

Dr. Jess LaRocca

Dr. Jess LaRocca

Corteva

Compound and In vivo Data Workstream Lead, Agchem Sector Co-Lead

Dr. Josh Harrill

Dr. Josh Harrill

EPA 

Study Design Workstream Lead, Public Sector Lead

Dr. Andreas Bender

Dr. Andreas Bender

Cambridge University

Integrative Data Analysis Workstream Lead 

Dr. Aaron Fullerton

Dr. Aaron Fullerton

Genentech

Pharma Sector Co-Lead

Dr. Sabah Kadri

Dr. Sabah Kadri

AbbVie

Pharma Sector Co-Lead

NK headshot 2023

Dr. Nicole Kleinstreuer

NIEHS

qIVIVE Workstream co-lead

Dr. Nynke Kramer

Dr. Nynke Kramer

Wageningen University

qIVIVE Workstream co-lead

deidre

Dr. Deidre Dalmas

eSTAR Chair Liaison

HESI Staff

Chrissy Crute, PhD

Chrissy Crute, PhD

Connie Mitchell, MS

Connie Mitchell, MS

Syril Pettit, DrPH

Syril Pettit, DrPH

Liisa Koskii, MS

Liisa Koskii, MS

Leadership

oasis workstream